In 2023, the Measles-Containing-Vaccine Second-Dose (MCV2) immunization coverage for children of the nationally recommended age in Brazil stood at 56%. The forecast data from 2024 to 2028 indicates that this value is expected to remain stable at 56%. Over this period, there are no expected year-on-year changes or variations, suggesting a stagnant pattern in vaccination coverage.
Looking ahead, it will be critical to monitor potential developments such as policy changes, public health campaigns, or socio-economic shifts that could impact MCV2 vaccine uptake. Enhanced public health efforts may be required to drive improvements in future coverage rates.
